ABT-348

· AbbVie

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABT-348, covering 2013-11-06 to 2017-11-20. Get the full timeline:

Most recent: Clinical Trial Update: ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies [Phase 1]